| USD millions | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 15.0 | 23.3 | 62.1 | +166.6% | |
| Selling, general & administrative | 2.4 | 3.5 | 10.3 | +194.2% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 17.3 | 26.8 | 72.3 | +170.2% | |
| Operating income | (17.3) | (26.8) | (72.3) | −170.2% | |
| Interest expense | 0.0 | 0.6 | 0.0 | −100.0% | |
| Interest income | 0.9 | 0.5 | 1.6 | +224.7% | |
| Other income / expense | 0.8 | 0.3 | 2.4 | +711.0% | |
| Pre-tax income | (16.5) | (26.5) | (70.0) | −164.3% | |
| Income tax | 0.0 | 0.0 | 0.0 | — | |
| Net income | (16.5) | (26.5) | (70.0) | −164.3% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.08) | (0.14) | (2.38) | −1600.0% | |
| EPS, diluted (per share) | (0.08) | (0.14) | (2.38) | −1600.0% | |
| EBITDA | (16.5) | (25.9) | (70.0) | −170.2% | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | — | |
| Weighted average shares (shares) | 201,334,354 | 201,334,354 | 35,077,084 | −82.6% | |
| Weighted average diluted shares (shares) | 201,334,354 | 201,334,354 | 35,077,084 | −82.6% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
